The Cashflow Memo
SHOWNOTES
This episode runs a “five-and-a-half surprises for 2026” framework—contrarian macro + energy calls with real probability. Then the hosts do quick year-end check-ins across tech and healthcare, always tying the discussion back to incentives and cash-flow durability.
[00:20] Disclaimer Informational only, not investment advice—do your own work.
[00:30] Macro & Energy Surprises Framework The team borrows the “surprises” idea: predictions that aren’t consensus, but aren’t crazy either. The goal is to pressure-test narratives (and portfolios) against plausible alternate paths.
[01:24] Surprise: Debt-to-GNP Falls A scenario where the deficit shrinks enough that debt held by the public declines as a share of GNP—roughly a 1-point improvement. The key point: even a small move would be notable versus most developed peers, and could shift the “inevitable spiral” narrative.
[02:40] Surprise: NRC Issues 2 Reactor Construction Permits A call that 2026 becomes a real turning point for new nuclear builds, with two construction permits issued. Discussion includes whether the approvals could mix a traditional large reactor with an SMR—and what that would signal about regulatory momentum.
[04:39] Surprise: Private Fusion Hits Ignition Jason revisits his view that a private company hits an ignition-like milestone. They emphasize “breakthrough headlines” vs. “commercial timelines,” and why a credible proof point still matters for long-duration capital formation.
[05:57] Reality Check: Nuclear Economics A sober debate: nuclear’s bottleneck isn’t only engineering—it’s financing, capital recovery, and who bears overruns. They talk through the triangle of (1) ratepayers, (2) shareholders, and (3) government subsidy/guarantees, and why cost-of-capital can be the hidden constraint.
[08:43] Surprise: Gas Supply Stays Strong Hunt pushes back on “associated gas is about to roll over” claims, making the case that supply can remain resilient into 2026. The Permian and broader producer behavior matter more than single-basin narratives.
[10:05] Surprise: $5 Natural Gas Mike lays out the demand-side bull case: LNG exports plus data-center/behind-the-meter power demand could raise the marginal cost of supply and re-rate the price band. They also nod to second-order effects—power pricing, build cycles, and how quickly demand shows up in volumes.
[11:49] Surprise: China Oil Demand Re-Accelerates Jason argues China’s apparent “peak demand” could be more cyclical than structural. If growth reappears, it changes the oil balance and challenges a lot of complacent forward curves.
[12:34] Next Two Weeks Preview Same format continues: next week is tech surprises; the week after is healthcare surprises.
[12:54] Exhibit C: Oil Quick scan of oil levels and geopolitical headline risk. They acknowledge events (e.g., war-related disruption risk) can move markets, but avoid anchoring the base case on low-probability catalysts.
[13:25] Exhibit B: Natural Gas A fast look at the natural gas strip/structure and what it implies for producer incentives, hedging behavior, and future supply response. The key lens: where the curve says the market thinks the marginal molecule will come from.
[13:51] Exhibit A: US Government Finances A brisk review of fiscal dynamics and how political incentives shape spending and “temporary” programs. They focus on what’s durable vs. what’s campaign-cycle noise—and why “who pays” matters just as much as “how big.”
[17:31] Tech Updates Year-end thoughts on the AI stack: semis, infrastructure, and who captures the economics. They touch Nvidia’s positioning, how inference might evolve, and why architecture choices can shift cash-flow capture across the stack.
[18:24] Nvidia, Groq, and Inference Economics Discussion of low-latency inference and why specialized architectures can matter. They also talk about how talent/teams (acquihires) can be as strategically valuable as product roadmaps.
[19:21] Amazon’s Graviton Isn’t Getting Enough Credit Jason argues CPUs still matter—especially for cloud cost structure and workload efficiency. Amazon’s internal chip strategy is framed as a quiet, compounding advantage that can support margins and pricing power.
[20:28] Nvidia + Intel Collaboration Angle A quick note on deeper CPU–accelerator integration as a strategic theme. If tight coupling improves performance-per-dollar, it can reshape parts of the ecosystem and change who wins incremental spend.
[21:09] Healthcare Updates Preview themes for the next episode: opioids, depression treatments, and drug pricing/negotiation. They frame healthcare as an incentives game—policy, reimbursement, and utilization drive outcomes as much as clinical innovation.
[22:31] ACA Subsidies, Medicaid, and Incentives A candid discussion of political messaging vs. system mechanics. They highlight how subsidies and program design can increase utilization and spending—and why that’s hard to reverse.
[25:30] Can Healthcare Spending Grow Slower Than the Economy? They explore what could actually bend the cost curve (transparency, enforcement, pricing power shifts) versus what tends to fail because incentives push costs higher over time.
[27:52] Wrap-Up Closing thoughts and a simple plan: next week is tech surprises, then healthcare surprises. Subscribe and grab the Cash Flow Memo if you want the updated financial context alongside the discussion.
MS 0.00%↑ VST 0.00%↑ CEG 0.00%↑ NRG 0.00%↑ SO 0.00%↑ D 0.00%↑ NVDA 0.00%↑ TSM 0.00%↑ ASML 0.00%↑ ORCL 0.00%↑ AVGO 0.00%↑ AMZN 0.00%↑ INTC 0.00%↑ ARM 0.00%↑ UNH 0.00%↑ GOOGL 0.00%↑
How did you like this week’s Telltales? Your feedback helps me make this great.
Loved | Great | Good | Meh | Bad | ….. If you liked this post from Telltales, why not share it?
This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.
